Loading
Latest filing published 11 Jul 2022 for Entasis Therapeutics Holdings Inc., €48k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Howard Mayer on record concern Entasis Therapeutics Holdings Inc., in the capacity of board member. Between 18 January 2022 and 7 July 2022, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 11 July 2022 came the latest disclosure, a transaction for €48k in Entasis Therapeutics Holdings Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations